Related references
Note: Only part of the references are listed.Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)
Thomas M. MacDonald et al.
EUROPEAN HEART JOURNAL (2017)
Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial
Francis K. L. Chan et al.
LANCET (2017)
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity
J. Q. Yuan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations
Gwen M. C. Masclee et al.
GASTROENTEROLOGY (2014)
GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial
Byron Cryer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Meta-analysis: cyclooxygenase-2 inhibitors are no better than nonselective nonsteroidal anti-inflammatory drugs with proton pump inhibitors in regard to gastrointestinal adverse events in osteoarthritis and rheumatoid arthritis
Xin Wang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract
Francis K. L. Chan et al.
JOURNAL OF RHEUMATOLOGY (2010)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial
Francis K. L. Chan et al.
LANCET (2010)
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
Matthew C. Becker et al.
AMERICAN HEART JOURNAL (2009)
Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study
E. Rahme et al.
RHEUMATOLOGY (2007)
Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study
G Singh et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo
JL Goldstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Visible small-intestinal mucosal injury in chronic NSAID users
DY Graham et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial
TJ Schnitzer et al.
LANCET (2004)
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis
FKL Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs:: a randomised trial
FKL Chan et al.
LANCET (2002)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract
JJY Sung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
